Milestone Pharmaceuticals (MIST) Balance Sheet: Assets & Liabilities

Milestone Pharmaceuticals (MIST) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Milestone Pharmaceuticals reported total assets of $113.56M and total liabilities of $71.79M. Shareholders' equity was $41.77M, up 217.7% from $13.15M a year earlier. Total debt stood at $58.38M against $105.96M in cash and short-term investments, a net cash position of $47.58M. That puts debt-to-equity at 1.40, compared with 4.17 a year earlier.

Milestone Pharmaceuticals Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Milestone Pharmaceuticals Inc. (MIST) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	73.05	25.31	13.76	7.64	114.14	72.31	119.82	85.95	10.88
Short-Term Investments	32.91	44.38	52.24	56.95	0.00	70.00	0.00	0.03	16.03
Cash & Short-Term Investments	105.96	69.70	66.00	64.59	114.14	142.31	119.82	85.98	26.91
Accounts Receivable	3.51	2.39	3.85	1.21	0.48	0.00	0.00	0.68	0.54
Inventory	0.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	1.81	1.84	3.18	6.01	4.30	6.38	2.68	1.40	0.10
Total Current Assets	111.92	73.93	73.03	71.80	118.92	148.69	122.50	88.05	27.56
Non-Current Assets
Property, Plant & Equipment (Net)	1.64	1.57	2.19	2.68	0.93	1.29	0.93	0.03	0.04
Other Non-Current Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Assets	1.64	1.57	2.19	2.68	0.93	1.29	0.93	0.03	0.04
Total Assets	113.56	75.50	75.23	74.48	119.85	149.97	123.43	88.08	27.59
Current Liabilities
Accounts Payable	5.65	1.93	3.98	2.26	6.55	4.64	4.38	2.60	0.00
Short-Term Debt	0.65	0.57	0.55	0.50	0.22	0.25	0.33	0.00	0.00
Accrued Liabilities	5.19	3.12	1.99	0.81	2.17	1.27	-	-	-
Other Current Liabilities	7.69	5.62	2.70	3.38	2.17	1.27	3.62	1.87	1.60
Total Current Liabilities	13.98	8.13	7.23	6.14	6.78	6.16	8.33	4.53	1.61
Non-Current Liabilities
Long-Term Debt	57.73	54.23	49.77	2.00	0.47	0.70	0.18	0.00	0.00
Other Non-Current Liabilities	0.08	0.00	0.00	0.00	0.00	0.00	0.00	138.76	59.10
Total Non-Current Liabilities	57.81	54.23	51.23	2.00	0.47	0.70	0.18	138.76	59.10
Total Liabilities	71.79	62.35	58.46	8.14	7.25	6.86	8.51	143.29	60.71
Stockholders' Equity
Common Stock	352.62	288.05	260.50	273.90	251.90	251.68	226.25	2.04	1.23
Retained Earnings	-430.60	-367.55	-326.03	-266.34	-207.95	-163.47	-113.50	-58.27	-35.09
Accumulated Other Comprehensive Income	55.65	53.08	48.46	34.35	52.94	46.37	-1.63	-1.63	-1.63
Additional Paid-in Capital	64.10	39.57	33.83	24.44	15.71	8.53	3.81	1.03	2.37
Shares Outstanding	106.24	53.35	33.48	34.29	29.90	-	-	-	-
Total Stockholders' Equity	41.77	13.15	16.77	66.35	112.60	143.12	114.92	-55.21	-33.12
Total Liabilities & Equity	113.56	75.50	75.23	74.48	119.85	149.97	123.43	88.08	27.59

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Milestone Pharmaceuticals Balance Sheet

How much debt does Milestone Pharmaceuticals have?

Milestone Pharmaceuticals had total debt of $58.38M as of Dec 31, 2025, against $105.96M in cash and short-term investments. Its debt-to-equity ratio was 1.40. Total debt was $54.80M a year earlier.

What are Milestone Pharmaceuticals's total assets?

Milestone Pharmaceuticals reported total assets of $113.56M as of Dec 31, 2025, up 50.4% from $75.50M a year earlier. Total liabilities were $71.79M.

What is Milestone Pharmaceuticals's shareholders' equity?

Milestone Pharmaceuticals's shareholders' equity was $41.77M as of Dec 31, 2025, or about $0.39 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition